SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection

Recent clinical trial data suggest a cardiorenal protective effect of sodium glucose cotransporter 2 (SGLT2) inhibition. We demonstrate that chemical denervation in neurogenic hypertensive Schlager (BPH/2J) mice reduced blood pressure, improved glucose homeostasis, and reduced renal SGLT2 protein ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Herat, Lakshini Y., Magno, Aaron L., Rudnicka, Caroline, Hricova, Jana, Carnagarin, Revathy, Ward, Natalie C., Arcambal, Angelique, Kiuchi, Marcio G., Head, Geoff A., Schlaich, Markus P., Matthews, Vance B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046513/
https://www.ncbi.nlm.nih.gov/pubmed/32140623
http://dx.doi.org/10.1016/j.jacbts.2019.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046513/
https://www.ncbi.nlm.nih.gov/pubmed/32140623
http://dx.doi.org/10.1016/j.jacbts.2019.11.007

Ejemplares similares